Arsenic exposure, hyperuricemia, and gout in US adults

Environment International

Volumn 76, Issue , 2015, Pages 32-40

  Kuo, Chin Chi ^a,b,c   Weaver, Virginia ^a,b,d   Fadrowski, Jeffrey J ^b,d   Lin, Yu Sheng ^e,f   Guallar, Eliseo ^a,b,d   Navas Acien, Ana ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

^f U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Arsenic; Gout; Hyperuricemia; Lead; Uric acid

Indexed keywords

LEAD; ORGANIC ACIDS;

ARSENIC EXPOSURE; CROSS-SECTIONAL STUDY; GOUT; HYPERURICEMIA; INTER QUARTILE RANGES; LIMITED INFORMATION; SOCIO-DEMOGRAPHIC FACTORS; URIC ACIDS;

ARSENIC;

ARSENIC; ARSENOBETAINE; CACODYLIC ACID; DRINKING WATER; URIC ACID; ORGANOARSENIC DERIVATIVE;

ARSENIC; HEALTH IMPACT; LEAD; MENS HEALTH; PUBLIC HEALTH; SERUM; WOMENS HEALTH;

ADULT; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; EXPOSURE; FEMALE; GOUT; HUMAN; HYPERURICEMIA; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SELF REPORT; UNITED STATES; URIC ACID BLOOD LEVEL; AGED; BLOOD; CHEMICALLY INDUCED; ENVIRONMENTAL EXPOSURE; MIDDLE AGED; NUTRITION; PROSPECTIVE STUDY; RISK; SEX DIFFERENCE;

UNITED STATES;

ADULT; AGED; ARSENIC; ARSENICALS; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL EXPOSURE; FEMALE; GOUT; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; NUTRITION SURVEYS; ODDS RATIO; PREVALENCE; PROSPECTIVE STUDIES; SEX FACTORS; UNITED STATES; URIC ACID;

EID: 84916887431     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2014.11.015     Document Type: Article

References (50)

1. Ames B.N., Cathcart R., Schwiers E., Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc. Natl. Acad. Sci. U. S. A. 1981, 78:6858-6862.
2. Ayotte J.D., Gronberg J.M., Apodaca L.E. Trace elements and radon in groundwater across the United States, 1992-2003. Scientific Investigations Report 2011-5059 2011.
3. Bandaru P., Shankar A. Association between serum uric acid levels and diabetes mellitus. Int. J. Endocrinol. 2011, 2011:604715.
4. Barr D.B., Wilder L.C., Caudill S.P., Gonzalez A.J., Needham L.L., Pirkle J.L. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ. Health Perspect. 2005, 113:192-200.
5. Bhole V., de Vera M., Rahman M.M., Krishnan E., Choi H. Epidemiology of gout in women: fifty-two-year followup of a prospective cohort. Arthritis Rheum. 2010, 62:1069-1076.
6. Caldwell K.L., Jones R.L., Verdon C.P., Jarrett J.M., Caudill S.P., Osterloh J.D. Levels of urinary total and speciated arsenic in the us population: National Health and Nutrition Examination Survey 2003-2004. J. Expo. Sci. Environ. Epidemiol. 2009, 19:59-68.
7. Campion E.W., Glynn R.J., DeLabry L.O. Asymptomatic hyperuricemia. Risks and consequences in the normative aging study. Am. J. Med. 1987, 82:421-426.
8. Centers for Disease Control and Prevention (CDC) Us Department of Health and Human Services. Third National Report on Human Exposure to Environmental Chemicals 2005, Centers for Disease Control and Prevention, Atlanta, GA.
9. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics. Centers for Disease Control and Prevention Website. Documentation, codebook, & frequencies: laboratory component: total and speciated arsenic NHANES 2003-2004, 2005-2006, 2007-2008, 2009-2010.
10. Centers for Disease Control and Prevention (CDC). National Health and Nutrition Examination Survey (NHANES). Laboratory procedure manual. 2003-4, 2005-6, 2007-8, 2009-10.
11. Choi H.K., Atkinson K., Karlson E.W., Willett W., Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N. Engl. J. Med. 2004, 350:1093-1103.
12. Choi H.K., Mount D.B., Reginato A.M. Pathogenesis of gout. Ann. Intern. Med. 2005, 143:499-516.
13. Choi H.K., Willett W., Curhan G. Coffee consumption and risk of incident gout in men: a prospective study. Arthritis Rheum. 2007, 56:2049-2055.
14. Choi H.K., Willett W., Curhan G. Fructose-rich beverages and risk of gout in women. JAMA 2010, 304:2270-2278.
15. De Souza A., Fernandes V., Ferrari A.J. Female gout: clinical and laboratory features. J. Rheumatol. 2005, 32:2186-2188.
16. Dehghan A., van Hoek M., Sijbrands E.J., Hofman A., Witteman J.C. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008, 31:361-362.
17. Del-Razo L.M., Garcia-Montalvo E.A., Valenzuela O.L. Arsenic exposure alters purine metabolism in rats, mice, and humans. Arsenic Exposure and Health Effects V 2003, Elsevier, Amsterdam. W.R. Chappell, C.O. Abernathy, R.L. Calderon, D.J. Thomas (Eds.).
18. Doherty M. New insights into the epidemiology of gout. Rheumatology (Oxford) 2009, 48(Suppl. 2):ii2-ii8.
19. Feig D.I., Kang D.H., Johnson R.J. Uric acid and cardiovascular risk. N. Engl. J. Med. 2008, 359:1811-1821.
20. Gelber A.C., Klag M.J., Mead L.A., Thomas J., Thomas D.J., Pearson T.A., Hochberg M.C. Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study. Arch. Intern. Med. 1997, 157:1436-1440.
21. Harrold L.R., Yood R.A., Mikuls T.R., Andrade S.E., Davis J., Fuller J., Chan K.A., Roblin D., Raebel M.A., Von Worley A., Platt R., Saag K.G. Sex differences in gout epidemiology: evaluation and treatment. Ann. Rheum. Dis. 2006, 65:1368-1372.
22. Hornung R.W., Reed L.D. Estimation of average concentration in the presence of nondetectable values. Appl. Occup. Environ. Hyg. 1990, 5:46-51.
23. Iseki K., Ikemiya Y., Inoue T., Iseki C., Kinjo K., Takishita S. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort. Am. J. Kidney Dis. 2004, 44:642-650.
24. Jauge P., Del-Razo L.M. Uric acid levels in plasma and urine in rats chronically exposed to inorganic as (III) and as (V). Toxicol. Lett. 1985, 26:31-35.
25. Kramer C.K., von Muhlen D., Jassal S.K., Barrett-Connor E. Serum uric acid levels improve prediction of incident type 2 diabetes in individuals with impaired fasting glucose: the Rancho Bernardo Study. Diabetes Care 2009, 32:1272-1273.
26. Krishnan E., Baker J.F., Furst D.E., Schumacher H.R. Gout and the risk of acute myocardial infarction. Arthritis Rheum. 2006, 54:2688-2696.
27. Krishnan E., Lingala B., Bhalla V. Low-level lead exposure and the prevalence of gout: an observational study. Ann. Intern. Med. 2012, 157:233-241.
28. Kristiansen J., Christensen J.M., Iversen B.S., Sabbioni E. Toxic trace element reference levels in blood and urine: Influence of gender and lifestyle factors. Sci. Total Environ. 1997, 204:147-160.
29. Lu J.M., Lin P.H., Yao Q., Chen C. Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems. J. Cell. Mol. Med. 2010, 14:840-860.
30. Maesaka J.K., Fishbane S. Regulation of renal urate excretion: a critical review. Am. J. Kidney Dis. 1998, 32:917-933.
31. Mahaffey K.R., Fowler B.A. Effects of concurrent administration of lead, cadmium, and arsenic in the rat. Environ. Health Perspect. 1977, 19:165-171.
32. Maiti S., Chattopadhyay S., Deb B., Samanta T., Maji G., Pan B., Ghosh A., Ghosh D. Antioxidant and metabolic impairment result in DNA damage in arsenic-exposed individuals with severe dermatological manifestations in eastern India. Environ. Toxicol. 2012, 27(6):342-350.
33. McAdams M.A., Maynard J.W., Baer A.N., Kottgen A., Clipp S., Coresh J., Gelber A.C. Reliability and sensitivity of the self-report of physician-diagnosed gout in the campaign against cancer and heart disease and the atherosclerosis risk in the community cohorts. J. Rheumatol. 2011, 38:135-141.
34. Moon K.A., Guallar E., Umans J.G., Devereux R.B., Best L.G., Francesconi K.A., Goessler W., Pollak J., Silbergeld E.K., Howard B.V., Navas-Acien A. Association between exposure to low to moderate arsenic levels and incident cardiovascular disease: a prospective cohort study. Ann. Intern. Med. 2013, 159:649-659.
35. Mukherjee C., White H., Wuyts M. Econometrics and Data Analysis For Developing Countries 1998, Routledge, London.
36. Nakagawa T., Kang D.H., Feig D., Sanchez-Lozada L.G., Srinivas T.R., Sautin Y., Ejaz A.A., Segal M., Johnson R.J. Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease. Kidney Int. 2006, 69:1722-1725.
37. Nan H., Dong Y., Gao W., Tuomilehto J., Qiao Q. Diabetes associated with a low serum uric acid level in a general Chinese population. Diabetes Res. Clin. Pract. 2007, 76:68-74.
38. National Health and Nutrition Examination Survey (NHANES) 2007-2008 Data Documentation, Codebook, and Frequencies: Urinary Albumin and Urinary Creatinine (ALB_CR_E) 2009.
39. Navas-Acien A., Nachman K.E. Public health responses to arsenic in rice and other foods. JAMA Intern. Med. 2013, 173:1395-1396.
40. Navas-Acien A., Silbergeld E.K., Pastor-Barriuso R., Guallar E. Arsenic exposure and prevalence of type 2 diabetes in us adults. JAMA 2008, 300:814-822.
41. Navas-Acien A., Francesconi K.A., Silbergeld E.K., Guallar E. Seafood intake and urine concentrations of total arsenic, dimethylarsinate and arsenobetaine in the US population. Environ. Res. 2011, 111:110-118.
42. NCHS (National Center for Health Statistics) National Health and Nutrition Examination Surveys 2012, (2012).
43. Ryu S., Chang Y., Zhang Y., Kim S.G., Cho J., Son H.J., Shin H., Guallar E. A cohort study of hyperuricemia in middle-aged South Korean men. Am. J. Epidemiol. 2012, 175:133-143.
44. Saxena P.N., Anand S., Saxena N., Bajaj P. Effect of arsenic trioxide on renal functions and its modulation by Curcuma aromatica leaf extract in albino rat. J. Environ. Biol. 2009, 30:527-531.
45. Sun S.Z., Flickinger B.D., Williamson-Hughes P.S., Empie M.W. Lack of association between dietary fructose and hyperuricemia risk in adults. Nutr. Metab. (Lond.) 2010, 7:16.
46. Town M.H., Gehm S., Hammer B., Ziegenhorn Z. A sensitive colorimetric method for the enzymatic determination of uric acid. J. Clin. Chem. Clin. Biochem. 1985, 23:591.
47. Wang D.D., Sievenpiper J.L., de Souza R.J., Chiavaroli L., Ha V., Cozma A.I., Mirrahimi A., Yu M.E., Carleton A.J., Di Buono M., Jenkins A.L., Leiter L.L., Wolever T.M., Beyene J., Kendall C.W., Jenkins D.J. The effects of fructose intake on serum uric acid vary among controlled dietary trials. J. Nutr. 2012, 142:916-923.
48. Weaver A.L. Epidemiology of gout. Cleve. Clin. J. Med. 2008, 75(Suppl. 5):S9-S12.
49. Zhang L., Spencer K.L., Voruganti V.S., Jorgensen N.W., Fornage M., Best L.G., Brown-Gentry K.D., Cole S.A., Crawford D.C., Deelman E., Franceschini N., Gaffo A.L., Glenn K.R., Heiss G., Jenny N.S., Kottgen A., Li Q., Liu K., Matise T.C., North K.E., Umans J.G., Kao W.H. Association of functional polymorphism rs2231142 (q141k) in the abcg2 gene with serum uric acid and gout in 4 US populations: the PAGE study. Am. J. Epidemiol. 2013, 177:923-932.
50. Zheng L.Y., Umans J.G., Tellez-Plaza M., Yeh F., Francesconi K.A., Goessler W., Silbergeld E.K., Guallar E., Howard B.V., Weaver V.M., Navas-Acien A. Urine arsenic and prevalent albuminuria: evidence from a population-based study. Am. J. Kidney Dis. 2012, 61:385-394.